Company profile: North Georgia Clinical Research
1.1 - Company Overview
Company description
- Provider of FDA-approved clinical trials evaluating new treatments and medications for various health conditions, conducted at its Woodstock, GA facility. Studies include an Alzheimer's prevention study, cardiovascular and diabetes trials, elevated lipoprotein(a) research, and a high cholesterol study testing an oral investigational drug to lower LDL-C and reduce cardiovascular risk.
Products and services
- Alzheimer’s Prevention Study: Facility-based clinical study focused on preventing Alzheimer’s disease, conducted at the Woodstock facility for patients interested in clinical research opportunities within the local community
- Clinical Trials: FDA-approved clinical trials evaluate new treatments and medications for various health conditions, delivered by North Georgia Clinical Research to build community trust among patients interested in clinical research opportunities
- High Cholesterol Study: Investigational, oral-drug clinical trial testing LDL-C lowering to reduce cardiovascular risks, conducted by North Georgia Clinical Research to evaluate new cholesterol treatments within its community-focused clinical research
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to North Georgia Clinical Research
Food and Drug Analytical Services
HQ: United Kingdom
Website
- Description: Provider of independent pharmaceutical quality control testing, delivering full contract testing services incorporating chemistry, microbiology, stability, and development capabilities to some of the UK's largest pharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Food and Drug Analytical Services company profile →
Adams Clinical
HQ: United States
Website
- Description: Provider of late-phase psychiatric and neurologic clinical trials in Massachusetts, conducting double-blind, randomized, placebo-controlled studies on investigational drugs. Also runs open-label depression monitoring (TRAIT-MDD-107) and Alzheimer's studies: ABBV-552 (M23-515 AbroAD) for mild AD and remternetug (J1G-MC-LAKC TRAILRUNNER-ALZ-1) for early symptomatic AD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adams Clinical company profile →
Cambrian Bio
HQ: United States
Website
- Description: Provider of therapeutics to lengthen healthspan via a Distributed Development Company model, advancing programs targeting biological drivers of aging, including ATX-304 (a pan-AMPK activator for cardiometabolic diseases, Phase 1B), Tornado Therapeutics (developing mTOR inhibitors with novel selectivity profiles), and Telovance (a protein complex to enhance ex-vivo cell therapy expansion).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrian Bio company profile →
Lotus Clinical Research
HQ: United States
Website
- Description: Provider of full-service CRO services and a network of 20+ wholly-owned US clinical research sites for analgesic programs and trials in psychiatry, neurology, pain, and addiction. Services include project management, site selection and monitoring, EDC and data management, biostatistics, medical monitoring, medical writing, quality operations, placebo response mitigation, global rater training, scientific consultation, and metabolic disease trial support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lotus Clinical Research company profile →
eStudySite
HQ: United States
Website
- Description: Provider of clinical research services delivering study-related care and conducting inpatient and outpatient protocols, including first-in-human, pivotal, and post-marketing studies; specializing in infectious disease trials (antibiotics, antivirals, vaccines, diagnostics). Expertise in endocrinology, hepatology, dermatology, gastroenterology; infusion center; community recruitment; ICH/FDA/GCP-compliant, ACLS/BLS-certified staff.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eStudySite company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for North Georgia Clinical Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to North Georgia Clinical Research
2.2 - Growth funds investing in similar companies to North Georgia Clinical Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for North Georgia Clinical Research
4.2 - Public trading comparable groups for North Georgia Clinical Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →